+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Parkinson's Disease Market by Drug Class, by Medical Devices Devices, by Route of Administration, by Distribution Channel, and by Region

  • PDF Icon

    Report

  • 200 Pages
  • October 2024
  • Region: Global
  • Erevna Healthcare
  • ID: 6008311
The global Parkinson's disease market accounted for USD 3.60 billion in 2023 and is expected to reach USD 11.66 billion by 2034 with a CAGR of 11.26% during the forecast period 2024-2034. The market for Parkinson's disease will grow as a result of rising co-morbidity rates, government initiatives and healthcare policies, aging populations, increased awareness and education, and advancements in research and development.

The market for Parkinson's disease is growing as a result of government measures to improve access to treatment and improve the quality of healthcare, especially in developing nations. Prioritizing neurological illnesses and allocating funds for research and development are important aspects of healthcare policy that stimulate innovation and market growth. For instance, AbbVie reported positive Phase 3 findings in December 2023 for its investigational medication, ABBV-951, which treats psychosis in Parkinson's disease.

By drug class, the Levodopa/Carbidopa segment accounted for the highest revenue-grossing segment in the global Parkinson's disease market in 2023 owing to its effectiveness in managing motor symptoms and its long-standing status as a cornerstone therapy in Parkinson's disease treatment. For instance, Acorda Therapeutics reported encouraging Phase 2 data for their Parkinson's disease treatment candidate tozadenant in November 2023. Additionally, the MAO-B inhibitors and COMT inhibitors segment is predicted to grow at the fastest CAGR during the forecast period owing to their efficacy in adjunctive therapy, the increasing focus on combination therapies, and the introduction of novel formulations and delivery methods.

By medical devices, the deep brain stimulation (DBS) devices segment accounted for the highest revenue-grossing segment in the global Parkinson's disease market in 2023 owing to its proven efficacy in managing motor complications, technological advancements improving device performance and patient outcomes, and expanding adoption among neurologists and patients. For instance, Medtronic announced in December 2023 that a pivotal study for their adaptive deep brain stimulation system for Parkinson's disease would begin. Additionally, the Carbidopa/Levodopa enteral suspension (Duopa) delivery devices segment is predicted to grow at the fastest CAGR during the forecast period owing to its targeted delivery, enhanced efficacy in managing motor fluctuations and increasing adoption of continuous dopaminergic therapies for Parkinson's disease management.

By route of administration, the oral segment accounted for the highest revenue-grossing segment in the global Parkinson's disease market in 2023 owing to its convenience, established efficacy, patient preference, and wide availability of oral medications for symptom management. For instance, Novartis reported encouraging Phase 3 data in December 2023 on their gene treatment for advanced Parkinson's disease. Additionally, the subcutaneous and intestinal infusion segment is predicted to grow at the fastest CAGR during the forecast period owing to its ability to provide continuous drug delivery, improved efficacy in managing motor fluctuations, and growing interest in alternative administration routes for Parkinson's disease treatment.

By distribution channel, the hospital pharmacies segment accounted for the highest revenue-grossing segment in the global Parkinson's disease market in 2023 owing to its ability to dispense specialized medications and handle complex treatment regimens often associated with Parkinson's disease management, along with the availability of comprehensive healthcare services in hospital settings. For instance, in June 2023, Prometheus Biosciences, Inc. ("Prometheus") and Merck, which is known as MSD outside of the US and Canada, declared that the transaction was complete. Additionally, the online pharmacies segment is predicted to grow at the fastest CAGR during the forecast period owing to the increasing adoption of e-commerce platforms for medication purchases, convenience, wider accessibility, and the growing trend of telemedicine and digital healthcare services.

North American region is anticipated to have the highest revenue share during the forecast period owing to its advanced healthcare infrastructure, high prevalence of Parkinson's disease, strong research and development activities, and greater access to novel therapies and treatment options. Additionally, the Asia Pacific region is predicted to grow at the fastest CAGR during the forecast period owing to its large population base, increasing awareness about neurological disorders, rising healthcare expenditure, improving healthcare infrastructure, and a growing emphasis on research and development in the region. For instance, in May 2023, Just - Evotec Biologics, the Seattle-based subsidiary of Evotec SE, and Sandoz, a global leader in off-patent (generic and biosimilar) medicines, established a multi-year cooperation.

This extensive research report concentrates on the size and projections of the global and regional markets from 2023 to 2034.

Report Scope:

  • Base Year: 2023
  • Forecast Period: 2024-2034
  • Study Coverage
  • Market Forecast by Drug Class, Medical Devices, Route of Administration, and Distribution Channel
  • Market Forecast for 5 Regions and 17+ Countries
  • North America (U.S. and Canada)
  • Europe (Germany, France, UK, Spain, Italy, Russia, Rest of Europe)
  • Asia Pacific (China, Japan, India, Australia, South Korea, Rest of APAC)
  • Latin America (Brazil, Mexico, Argentina, Rest of LATAM)
  • MEA (South Africa, GCC, Rest of MEA)
  • Exhaustive Company Profiles of the Top 10+ Major Market Players
  • 20% Free Customization Available to Meet Your Exact Requirement

Segmentation: Parkinson’s Disease Market Report 2023 - 2034

Parkinson’s Disease Market Analysis & Forecast by Drug Class 2023 - 2034 (Revenue USD Bn)

  • Levodopa/Carbidopa
  • Dopamine Receptor Agonists
  • MAO-Inhibitors
  • COMT-Inhibitors
  • Anticholinergics
  • Other Drugs

Parkinson’s Disease Market Analysis & Forecast by Medical Devices 2023 - 2034 (Revenue USD Bn)

  • Deep Brain Stimulation (DBS) Devices
  • Carbidopa/Levodopa Enteral Suspension (Duopa) Delivery Devices

Parkinson’s Disease Market Analysis & Forecast by Route of Administration 2023 - 2034 (Revenue USD Bn)

  • Oral
  • Transdermal
  • Subcutaneous
  • Intestinal Infusion
  • Others

Parkinson’s Disease Market Analysis & Forecast by Distribution Channel 2023 - 2034 (Revenue USD Bn)

  • Hospital Pharmacies
  • Clinics
  • Retail Pharmacies
  • Online Pharmacies

Parkinson’s Disease Market Analysis & Forecast by Region 2023 - 2034 (Revenue USD Bn)

  • North America
  • U.S.
  • Canada
  • Europe
  • Germany
  • France
  • UK
  • Spain
  • Italy
  • Rest of Europe
  • Asia Pacific
  • China
  • Japan
  • India
  • Australia
  • South Korea
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Rest of LATAM
  • Middle East & Africa
  • South Africa
  • GCC
  • Rest of MEA

Table of Contents

1. Research Methodology
1.1. Study Objectives
1.2. Study Scope
1.3. Research Assumptions
1.4. Research Framework
2. Introduction
2.1. Market Definition
2.2. Global Parkinson’s Disease Market Overview
3. Executive Summary
4. Market Environment Analysis
4.1. Porter’s 5 Forces Analysis
4.2. PESTEL Analysis
4.3. SWOT Analysis
5. Market Dynamics
5.1. Drivers Analysis
5.2. Restraints Analysis
5.3. Opportunities Analysis
5.4. Threats Analysis
5.5. Trend Analysis
6. COVID-19 Impact Analysis
7. Parkinson’s Disease Market: Drug Class Estimates & Trend Analysis
7.1. Drug Class Segment Opportunity Analysis
7.2. Levodopa/Carbidopa
7.2.1. Levodopa/Carbidopa Market Analysis & Forecast, 2023-2034 (Revenue, USD Bn)
7.3. Dopamine Receptor Agonists
7.3.1. Dopamine Receptor Agonists Market Analysis & Forecast, 2023-2034 (Revenue, USD Bn)
7.4. MAO-Inhibitors
7.4.1. MAO-Inhibitors Market Analysis & Forecast, 2023-2034 (Revenue, USD Bn)
7.5. COMT-Inhibitors
7.5.1. COMT-Inhibitors Market Analysis & Forecast, 2023-2034 (Revenue, USD Bn)
7.6. Anticholinergics
7.6.1. Anticholinergics Market Analysis & Forecast, 2023-2034 (Revenue, USD Bn)
7.7. Other Drugs
7.7.1. Other Drugs Market Analysis & Forecast, 2023-2034 (Revenue, USD Bn)
8. Parkinson’s Disease Market: Medical Devices Estimates & Trend Analysis
8.1. Medical Devices Segment Opportunity Analysis
8.2. Deep Brain Stimulation (DBS) Devices
8.2.1. Deep Brain Stimulation (DBS) Devices Market Analysis & Forecast, 2023-2034 (Revenue, USD Bn)
8.3. Carbidopa/Levodopa Enteral Suspension (Duopa) Delivery Devices
8.3.1. Carbidopa/Levodopa Enteral Suspension (Duopa) Delivery Devices Market Analysis & Forecast, 2023-2034 (Revenue, USD Bn)
9. Parkinson’s Disease Market: Route of Administration Estimates & Trend Analysis
9.1. Route of Administration Segment Opportunity Analysis
9.2. Oral
9.2.1. Oral Market Analysis & Forecast, 2023-2034 (Revenue, USD Bn)
9.3. Transdermal
9.3.1. Transdermal Market Analysis & Forecast, 2023-2034 (Revenue, USD Bn)
9.4. Subcutaneous
9.4.1. Subcutaneous Market Analysis & Forecast, 2023-2034 (Revenue, USD Bn)
9.5. Intestinal Infusion
9.5.1. Intestinal Infusion Market Analysis & Forecast, 2023-2034 (Revenue, USD Bn)
9.6. Others
9.6.1. Others Market Analysis & Forecast, 2023-2034 (Revenue, USD Bn)
10. Parkinson’s Disease Market: Distribution Channel Estimates & Trend Analysis
10.1. Distribution Channel Segment Opportunity Analysis
10.2. Hospital Pharmacies
10.2.1. Hospital Pharmacies Market Analysis & Forecast, 2023-2034 (Revenue, USD Bn)
10.3. Clinics
10.3.1. Clinics Market Analysis & Forecast, 2023-2034 (Revenue, USD Bn)
10.4. Retail Pharmacies
10.4.1. Retail Pharmacies Market Analysis & Forecast, 2023-2034 (Revenue, USD Bn)
10.5. Online Pharmacies
10.5.1. Online Pharmacies Market Analysis & Forecast, 2023-2034 (Revenue, USD Bn)
11. Regional Market Analysis
11.1. Regional Market Opportunity Analysis
12. North America Parkinson’s Disease Market
12.1. North America Parkinson’s Disease Market
12.1.1. North America Parkinson’s Disease Market Size and Forecast, 2023-2034 (Revenue USD Bn)
12.1.2. North America Parkinson’s Disease Market Size and Forecast, By Country, 2023-2034 (Revenue USD Bn)
12.1.3. North America Parkinson’s Disease Market Size and Forecast, By Drug Class, 2023-2034 (Revenue USD Bn)
12.1.4. North America Parkinson’s Disease Market Size and Forecast, By Medical Devices, 2023-2034 (Revenue USD Bn)
12.1.5. North America Parkinson’s Disease Market Size and Forecast, By Route of Administration, 2023-2034 (Revenue USD Bn)
12.1.6. North America Parkinson’s Disease Market Size and Forecast, By Distribution Channel, 2023-2034 (Revenue USD Bn)
12.2. U.S. Global Parkinson’s Disease Market
12.2.1. U.S. Parkinson’s Disease Market Size and Forecast, 2023-2034 (Revenue USD Bn)
12.2.2. U.S. Parkinson’s Disease Market Size and Forecast, By Drug Class, 2023-2034 (Revenue USD Bn)
12.2.3. U.S. Parkinson’s Disease Market Size and Forecast, By Medical Devices, 2023-2034 (Revenue USD Bn)
12.2.4. U.S. Parkinson’s Disease Market Size and Forecast, By Route of Administration, 2023-2034 (Revenue USD Bn)
12.2.5. U.S. Parkinson’s Disease Market Size and Forecast, By Distribution Channel, 2023-2034 (Revenue USD Bn)
12.3. Canada Global Parkinson’s Disease Market
12.3.1. Canada Parkinson’s Disease Market Size and Forecast, 2023-2034 (Revenue USD Bn)
12.3.2. Canada Parkinson’s Disease Market Size and Forecast, By Drug Class, 2023-2034 (Revenue USD Bn)
12.3.3. Canada Parkinson’s Disease Market Size and Forecast, By Medical Devices, 2023-2034 (Revenue USD Bn)
12.3.4. Canada Parkinson’s Disease Market Size and Forecast, By Route of Administration, 2023-2034 (Revenue USD Bn)
12.3.5. Canada Parkinson’s Disease Market Size and Forecast, By Distribution Channel, 2023-2034 (Revenue USD Bn)
13. Europe Global Parkinson’s Disease Market
13.1. Europe Global Parkinson’s Disease Market
13.1.1. Europe Parkinson’s Disease Market Size and Forecast, 2023-2034 (Revenue USD Bn)
13.1.2. Europe Parkinson’s Disease Market Size and Forecast, By Country, 2023-2034 (Revenue USD Bn)
13.1.3. Europe Parkinson’s Disease Market Size and Forecast, By Drug Class, 2023-2034 (Revenue USD Bn)
13.1.4. Europe Parkinson’s Disease Market Size and Forecast, By Medical Devices, 2023-2034 (Revenue USD Bn)
13.1.5. Europe Parkinson’s Disease Market Size and Forecast, By Route of Administration, 2023-2034 (Revenue USD Bn)
13.1.6. Europe Parkinson’s Disease Market Size and Forecast, By Distribution Channel, 2023-2034 (Revenue USD Bn)
13.2. Germany Global Parkinson’s Disease Market
13.2.1. Germany Parkinson’s Disease Market Size and Forecast, 2023-2034 (Revenue USD Bn)
13.2.2. Germany Parkinson’s Disease Market Size and Forecast, By Drug Class, 2023-2034 (Revenue USD Bn)
13.2.3. Germany Parkinson’s Disease Market Size and Forecast, By Medical Devices, 2023-2034 (Revenue USD Bn)
13.2.4. Germany Parkinson’s Disease Market Size and Forecast, By Route of Administration, 2023-2034 (Revenue USD Bn)
13.2.5. Germany Parkinson’s Disease Market Size and Forecast, By Distribution Channel, 2023-2034 (Revenue USD Bn)
13.3. UK Global Parkinson’s Disease Market
13.3.1. UK Parkinson’s Disease Market Size and Forecast, 2023-2034 (Revenue USD Bn)
13.3.2. UK Parkinson’s Disease Market Size and Forecast, By Drug Class, 2023-2034 (Revenue USD Bn)
13.3.3. UK Parkinson’s Disease Market Size and Forecast, By Medical Devices, 2023-2034 (Revenue USD Bn)
13.3.4. UK Parkinson’s Disease Market Size and Forecast, By Route of Administration, 2023-2034 (Revenue USD Bn)
13.3.5. UK Parkinson’s Disease Market Size and Forecast, By Distribution Channel, 2023-2034 (Revenue USD Bn)
13.4. France Global Parkinson’s Disease Market
13.4.1. France Parkinson’s Disease Market Size and Forecast, 2023-2034 (Revenue USD Bn)
13.4.2. France Parkinson’s Disease Market Size and Forecast, By Drug Class, 2023-2034 (Revenue USD Bn)
13.4.3. France Parkinson’s Disease Market Size and Forecast, By Medical Devices, 2023-2034 (Revenue USD Bn)
13.4.4. France Parkinson’s Disease Market Size and Forecast, By Route of Administration, 2023-2034 (Revenue USD Bn)
13.4.5. France Parkinson’s Disease Market Size and Forecast, By Distribution Channel, 2023-2034 (Revenue USD Bn)
13.5. Spain Global Parkinson’s Disease Market
13.5.1. Spain Parkinson’s Disease Market Size and Forecast, 2023-2034 (Revenue USD Bn)
13.5.2. Spain Parkinson’s Disease Market Size and Forecast, By Drug Class, 2023-2034 (Revenue USD Bn)
13.5.3. Spain Parkinson’s Disease Market Size and Forecast, By Medical Devices, 2023-2034 (Revenue USD Bn)
13.5.4. Spain Parkinson’s Disease Market Size and Forecast, By Route of Administration, 2023-2034 (Revenue USD Bn)
13.5.5. Spain Parkinson’s Disease Market Size and Forecast, By Distribution Channel, 2023-2034 (Revenue USD Bn)
13.6. Italy Global Parkinson’s Disease Market
13.6.1. Italy Parkinson’s Disease Market Size and Forecast, 2023-2034 (Revenue USD Bn)
13.6.2. Italy Parkinson’s Disease Market Size and Forecast, By Drug Class, 2023-2034 (Revenue USD Bn)
13.6.3. Italy Parkinson’s Disease Market Size and Forecast, By Medical Devices, 2023-2034 (Revenue USD Bn)
13.6.4. Italy Parkinson’s Disease Market Size and Forecast, By Route of Administration, 2023-2034 (Revenue USD Bn)
13.6.5. Italy Parkinson’s Disease Market Size and Forecast, By Distribution Channel, 2023-2034 (Revenue USD Bn)
13.7. Rest of Europe Global Parkinson’s Disease Market
13.7.1. Rest of Europe Parkinson’s Disease Market Size and Forecast, 2023-2034 (Revenue USD Bn)
13.7.2. Rest of Europe Parkinson’s Disease Market Size and Forecast, By Drug Class, 2023-2034 (Revenue USD Bn)
13.7.3. Rest of Europe Parkinson’s Disease Market Size and Forecast, By Medical Devices, 2023-2034 (Revenue USD Bn)
13.7.4. Rest of Europe Parkinson’s Disease Market Size and Forecast, By Route of Administration, 2023-2034 (Revenue USD Bn)
13.7.5. Rest of Europe Parkinson’s Disease Market Size and Forecast, By Distribution Channel, 2023-2034 (Revenue USD Bn)
14. Asia Pacific Global Parkinson’s Disease Market
14.1. Asia Pacific Global Parkinson’s Disease Market
14.1.1. Asia Pacific Parkinson’s Disease Market Size and Forecast, 2023-2034 (Revenue USD Bn)
14.1.2. Asia Pacific Parkinson’s Disease Market Size and Forecast, By Country, 2023-2034 (Revenue USD Bn)
14.1.3. Asia Pacific Parkinson’s Disease Market Size and Forecast, By Drug Class, 2023-2034 (Revenue USD Bn)
14.1.4. Asia Pacific Parkinson’s Disease Market Size and Forecast, By Medical Devices, 2023-2034 (Revenue USD Bn)
14.1.5. Asia Pacific Parkinson’s Disease Market Size and Forecast, By Route of Administration, 2023-2034 (Revenue USD Bn)
14.1.6. Asia Pacific Parkinson’s Disease Market Size and Forecast, By Distribution Channel, 2023-2034 (Revenue USD Bn)
14.2. Japan Global Parkinson’s Disease Market
14.2.1. Japan Parkinson’s Disease Market Size and Forecast, 2023-2034 (Revenue USD Bn)
14.2.2. Japan Parkinson’s Disease Market Size and Forecast, By Drug Class, 2023-2034 (Revenue USD Bn)
14.2.3. Japan Parkinson’s Disease Market Size and Forecast, By Medical Devices, 2023-2034 (Revenue USD Bn)
14.2.4. Japan Parkinson’s Disease Market Size and Forecast, By Route of Administration, 2023-2034 (Revenue USD Bn)
14.2.5. Japan Parkinson’s Disease Market Size and Forecast, By Distribution Channel, 2023-2034 (Revenue USD Bn)
14.3. China Global Parkinson’s Disease Market
14.3.1. China Parkinson’s Disease Market Size and Forecast, 2023-2034 (Revenue USD Bn)
14.3.2. China Parkinson’s Disease Market Size and Forecast, By Drug Class, 2023-2034 (Revenue USD Bn)
14.3.3. China Parkinson’s Disease Market Size and Forecast, By Medical Devices, 2023-2034 (Revenue USD Bn)
14.3.4. China Parkinson’s Disease Market Size and Forecast, By Route of Administration, 2023-2034 (Revenue USD Bn)
14.3.5. China Parkinson’s Disease Market Size and Forecast, By Distribution Channel, 2023-2034 (Revenue USD Bn)
14.4. India Global Parkinson’s Disease Market
14.4.1. India Parkinson’s Disease Market Size and Forecast, 2023-2034 (Revenue USD Bn)
14.4.2. India Parkinson’s Disease Market Size and Forecast, By Drug Class, 2023-2034 (Revenue USD Bn)
14.4.3. India Parkinson’s Disease Market Size and Forecast, By Medical Devices, 2023-2034 (Revenue USD Bn)
14.4.4. India Parkinson’s Disease Market Size and Forecast, By Route of Administration, 2023-2034 (Revenue USD Bn)
14.4.5. India Parkinson’s Disease Market Size and Forecast, By Distribution Channel, 2023-2034 (Revenue USD Bn)
14.5. South Korea Global Parkinson’s Disease Market
14.5.1. South Korea Parkinson’s Disease Market Size and Forecast, 2023-2034 (Revenue USD Bn)
14.5.2. South Korea Parkinson’s Disease Market Size and Forecast, By Drug Class, 2023-2034 (Revenue USD Bn)
14.5.3. South Korea Parkinson’s Disease Market Size and Forecast, By Medical Devices, 2023-2034 (Revenue USD Bn)
14.5.4. South Korea Parkinson’s Disease Market Size and Forecast, By Route of Administration, 2023-2034 (Revenue USD Bn)
14.5.5. South Korea Parkinson’s Disease Market Size and Forecast, By Distribution Channel, 2023-2034 (Revenue USD Bn)
14.6. Australia Global Parkinson’s Disease Market
14.6.1. Australia Parkinson’s Disease Market Size and Forecast, 2023-2034 (Revenue USD Bn)
14.6.2. Australia Parkinson’s Disease Market Size and Forecast, By Drug Class, 2023-2034 (Revenue USD Bn)
14.6.3. Australia Parkinson’s Disease Market Size and Forecast, By Medical Devices, 2023-2034 (Revenue USD Bn)
14.6.4. Australia Parkinson’s Disease Market Size and Forecast, By Route of Administration, 2023-2034 (Revenue USD Bn)
14.6.5. Australia Parkinson’s Disease Market Size and Forecast, By Distribution Channel, 2023-2034 (Revenue USD Bn)
14.7. Rest of Asia Pacific Global Parkinson’s Disease Market
14.7.1. Rest of Asia Pacific Parkinson’s Disease Market Size and Forecast, 2023-2034 (Revenue USD Bn)
14.7.2. Rest of Asia Pacific Parkinson’s Disease Market Size and Forecast, By Drug Class, 2023-2034 (Revenue USD Bn)
14.7.3. Rest of Asia Pacific Parkinson’s Disease Market Size and Forecast, By Medical Devices, 2023-2034 (Revenue USD Bn)
14.7.4. Rest of Asia Pacific Parkinson’s Disease Market Size and Forecast, By Route of Administration, 2023-2034 (Revenue USD Bn)
14.7.5. Rest of Asia Pacific Parkinson’s Disease Market Size and Forecast, By Distribution Channel, 2023-2034 (Revenue USD Bn)
15. Latin America Global Parkinson’s Disease Market
15.1. Latin America Global Parkinson’s Disease Market
15.1.1. Latin America Parkinson’s Disease Market Size and Forecast, 2023-2034 (Revenue USD Bn)
15.1.2. Latin America Parkinson’s Disease Market Size and Forecast, By Country, 2023-2034 (Revenue USD Bn)
15.1.3. Latin America Parkinson’s Disease Market Size and Forecast, By Drug Class, 2023-2034 (Revenue USD Bn)
15.1.4. Latin America Parkinson’s Disease Market Size and Forecast, By Medical Devices, 2023-2034 (Revenue USD Bn)
15.1.5. Latin America Parkinson’s Disease Market Size and Forecast, By Route of Administration, 2023-2034 (Revenue USD Bn)
15.1.6. Latin America Parkinson’s Disease Market Size and Forecast, By Distribution Channel, 2023-2034 (Revenue USD Bn)
15.2. Brazil Global Parkinson’s Disease Market
15.2.1. Brazil Parkinson’s Disease Market Size and Forecast, 2023-2034 (Revenue USD Bn)
15.2.2. Brazil Parkinson’s Disease Market Size and Forecast, By Drug Class, 2023-2034 (Revenue USD Bn)
15.2.3. Brazil Parkinson’s Disease Market Size and Forecast, By Medical Devices, 2023-2034 (Revenue USD Bn)
15.2.4. Brazil Parkinson’s Disease Market Size and Forecast, By Route of Administration, 2023-2034 (Revenue USD Bn)
15.2.5. Brazil Parkinson’s Disease Market Size and Forecast, By Distribution Channel, 2023-2034 (Revenue USD Bn)
15.3. Mexico Global Parkinson’s Disease Market
15.3.1. Mexico Parkinson’s Disease Market Size and Forecast, 2023-2034 (Revenue USD Bn)
15.3.2. Mexico Parkinson’s Disease Market Size and Forecast, By Drug Class, 2023-2034 (Revenue USD Bn)
15.3.3. Mexico Parkinson’s Disease Market Size and Forecast, By Medical Devices, 2023-2034 (Revenue USD Bn)
15.3.4. Mexico Parkinson’s Disease Market Size and Forecast, By Route of Administration, 2023-2034 (Revenue USD Bn)
15.3.5. Mexico Parkinson’s Disease Market Size and Forecast, By Distribution Channel, 2023-2034 (Revenue USD Bn)
15.4. Argentina Global Parkinson’s Disease Market
15.4.1. Argentina Parkinson’s Disease Market Size and Forecast, 2023-2034 (Revenue USD Bn)
15.4.2. Argentina Parkinson’s Disease Market Size and Forecast, By Drug Class, 2023-2034 (Revenue USD Bn)
15.4.3. Argentina Parkinson’s Disease Market Size and Forecast, By Medical Devices, 2023-2034 (Revenue USD Bn)
15.4.4. Argentina Parkinson’s Disease Market Size and Forecast, By Route of Administration, 2023-2034 (Revenue USD Bn)
15.4.5. Argentina Parkinson’s Disease Market Size and Forecast, By Distribution Channel, 2023-2034 (Revenue USD Bn)
15.5. Rest of Latin America Global Parkinson’s Disease Market
15.5.1. Rest of Latin America Parkinson’s Disease Market Size and Forecast, 2023-2034 (Revenue USD Bn)
15.5.2. Rest of Latin America Parkinson’s Disease Market Size and Forecast, By Drug Class, 2023-2034 (Revenue USD Bn)
15.5.3. Rest of Latin America Parkinson’s Disease Market Size and Forecast, By Medical Devices, 2023-2034 (Revenue USD Bn)
15.5.4. Rest of Latin America Parkinson’s Disease Market Size and Forecast, By Route of Administration, 2023-2034 (Revenue USD Bn)
15.5.5. Rest of Latin America Parkinson’s Disease Market Size and Forecast, By Distribution Channel, 2023-2034 (Revenue USD Bn)
16. MEA Global Parkinson’s Disease Market
16.1. MEA Global Parkinson’s Disease Market
16.1.1. MEA Parkinson’s Disease Market Size and Forecast, 2023-2034 (Revenue USD Bn)
16.1.2. MEA Parkinson’s Disease Market Size and Forecast, By Country, 2023-2034 (Revenue USD Bn)
16.1.3. MEA Parkinson’s Disease Market Size and Forecast, By Drug Class, 2023-2034 (Revenue USD Bn)
16.1.4. MEA Parkinson’s Disease Market Size and Forecast, By Medical Devices, 2023-2034 (Revenue USD Bn)
16.1.5. MEA Parkinson’s Disease Market Size and Forecast, By Route of Administration, 2023-2034 (Revenue USD Bn)
16.1.6. MEA Parkinson’s Disease Market Size and Forecast, By Distribution Channel, 2023-2034 (Revenue USD Bn)
16.2. GCC Global Parkinson’s Disease Market
16.2.1. GCC Parkinson’s Disease Market Size and Forecast, 2023-2034 (Revenue USD Bn)
16.2.2. GCC Parkinson’s Disease Market Size and Forecast, By Drug Class, 2023-2034 (Revenue USD Bn)
16.2.3. GCC Parkinson’s Disease Market Size and Forecast, By Medical Devices, 2023-2034 (Revenue USD Bn)
16.2.4. GCC Parkinson’s Disease Market Size and Forecast, By Route of Administration, 2023-2034 (Revenue USD Bn)
16.2.5. GCC Parkinson’s Disease Market Size and Forecast, By Distribution Channel, 2023-2034 (Revenue USD Bn)
16.3. South Africa Global Parkinson’s Disease Market
16.3.1. South Africa Parkinson’s Disease Market Size and Forecast, 2023-2034 (Revenue USD Bn)
16.3.2. South Africa Parkinson’s Disease Market Size and Forecast, By Drug Class, 2023-2034 (Revenue USD Bn)
16.3.3. South Africa Parkinson’s Disease Market Size and Forecast, By Medical Devices, 2023-2034 (Revenue USD Bn)
16.3.4. South Africa Parkinson’s Disease Market Size and Forecast, By Route of Administration, 2023-2034 (Revenue USD Bn)
16.3.5. South Africa Parkinson’s Disease Market Size and Forecast, By Distribution Channel, 2023-2034 (Revenue USD Bn)
16.4. Rest of MEA Global Parkinson’s Disease Market
16.4.1. Rest of MEA Parkinson’s Disease Market Size and Forecast, 2023-2034 (Revenue USD Bn)
16.4.2. Rest of MEA Parkinson’s Disease Market Size and Forecast, By Drug Class, 2023-2034 (Revenue USD Bn)
16.4.3. Rest of MEA Parkinson’s Disease Market Size and Forecast, By Medical Devices, 2023-2034 (Revenue USD Bn)
16.4.4. Rest of MEA Parkinson’s Disease Market Size and Forecast, By Route of Administration, 2023-2034 (Revenue USD Bn)
16.4.5. Rest of MEA Parkinson’s Disease Market Size and Forecast, By Distribution Channel, 2023-2034 (Revenue USD Bn)
17. Competitor Analysis
17.1. Company Market Share Analysis, 2023
17.2. Major Recent Developments
18. Company Profiles
18.1. AbbVie Inc.
18.2. Acorda Therapeutics, Inc.
18.3. Adamas Pharmaceuticals, Inc.
18.4. Amneal Pharmaceuticals, Inc.
18.5. Apopharma Inc.
18.6. BIAL - Portela & Cª, S.A.
18.7. Impax Laboratories, LLC.
18.8. Lundbeck A/S
18.9. Medtronic plc
18.10. Merck & Co., Inc.
18.11. Neurocrine Biosciences, Inc.
18.12. Novartis AG
18.13. Teva Pharmaceutical Industries Ltd.
18.14. UCB S.A.
18.15. Voyager Therapeutics, Inc.
19. Conclusion20. Recommendations

Companies Mentioned

  • AbbVie Inc.
  • Acorda Therapeutics Inc.
  • Adamas Pharmaceuticals Inc.
  • Amneal Pharmaceuticals Inc.
  • Apopharma Inc.
  • BIAL - Portela & Cª S.A.
  • Impax Laboratories LLC.
  • Lundbeck A/S
  • Medtronic plc
  • Merck & Co. Inc.
  • Neurocrine Biosciences Inc.
  • Novartis AG
  • Teva Pharmaceutical Industries Ltd.
  • UCB S.A.
  • Voyager Therapeutics Inc.

Table Information